NAME : Mr. S.N.SHARMA REG/LAB NO.
: 25060498 / 14020
AGE/SEX : 66 Yrs / Male DATE OF COLLECTION : 19-06-2025 at 09:26 AM
REFERRED BY : SELF DATE OF REPORT : 19-06-2025 at 02:38 PM
CONTACT NO. : 9182211565 DATE OF RECEIVED : 19-06-2025 at 09:26 AM
TEST PARAMETER RESULT REFERENCE RANGE
GLYCOSYLATED HEMOGLOBIN(HBA1C), EDTA WHOLE BLOOD
HbA1c 6.1 % 0 - 6.4 %
HPLC
Non-diabetic Adult < 5.7
Pre-diabetes 5.7 - 6.4
Diabetes diagnosis: > or = 6.5
Therapeutic goals: < 7.0
Action suggested : > 8.0
(ADA Guideline 2021)
ESTIMATED AVERAGE GLUCOSE(EAG) 127.3 mg/dl < 116.0
Interpretation(s)
GLYCOSYLATED HEMOGLOBIN(HBA1C), EDTA WHOLE BLOOD-Used For:
1. Evaluating the long-term control of blood glucose concentrations in diabetic patients.
2. Diagnosing diabetes.
3. Identifying patients at increased risk for diabetes (prediabetes).
The ADA recommends measurement of HbA1c (typically 3-4 times per year for type 1 and poorly controlled type 2 diabetic patients, and 2 times per year for
well-controlled type 2 diabetic patients) to determine whether a patients metabolic control has remained continuously within the target range.
1. eAG (Estimated average glucose) converts percentage HbA1c to md/dl, to compare blood glucose levels.
2. eAG gives an evaluation of blood glucose levels for the last couple of months.
3. eAG is calculated as eAG (mg/dl) = 28.7 * HbA1c - 46.7
HbA1c Estimation can get affected due to :
1. Shortened Erythrocyte survival : Any condition that shortens erythrocyte survival or decreases mean erythrocyte age (e.g. recovery from acute blood loss,hemolytic
anemia) will falsely lower HbA1c test results.Fructosamine is recommended in these patients which indicates diabetes control over 15 days.
2.Vitamin C & E are reported to falsely lower test results.(possibly by inhibiting glycation of hemoglobin.
3. Iron deficiency anemia is reported to increase test results. Hypertriglyceridemia,uremia, hyperbilirubinemia, chronic alcoholism,chronic ingestion of salicylates & opiates
addiction are reported to interfere with some assay methods,falsely increasing results.
4. Interference of hemoglobinopathies in HbA1c estimation is seen in
a) Homozygous hemoglobinopathy. Fructosamine is recommended for testing of HbA1c.
b) Heterozygous state detected (D10 is corrected for HbS & HbC trait.)
c) HbF > 25% on alternate paltform (Boronate affinity chromatography) is recommended for testing of HbA1c.Abnormal Hemoglobin electrophoresis (HPLC method) is
recommended for detecting a hemoglobinopathy
Dispatched by: Chandrasekar **** End of Report **** Printed by: Chandrasekar on 19-06-2025 at 02:38 PM
SAI DINESH REDDY Dr. RAJALAXMI G
Sr. LAB TECHNICIAN MBBS MD
CONSULTANT PATHOLOGIST
Page 1 of 1
